Effie Alberta Read’s biography, net worth, fact, career, awards and life story

Intro American scientist
Was Scientist 
From United States of America 
Type Science 
Gender female
Birth 1873, Haverhill
Death 1 September 1930
(aged 57 years)
You May Also Like

Michael Shanks’s net worth, biography, fact, career, awards and life story

Michael Shanks Net Worth: Michael Shanks is a Canadian actor who has a net worth of $2 million. Michael Shanks was born in 1970 in Vancouver, British Columbia, Canada. Shanks studied at the University of British Columbia, where he starred in several stage productions. He made his screen debut in 1993 with an appearance in “Highlander”. Four years later, he landed the part for which he is best known today, playing Dr. Daniel Jackson and voicing Thor in “Stargate SG-1”. Shanks appeared on the show from 1997 until 2002 and again from 2003 until 2007. He also starred in the spin-off films, “Stargate: The Ark of Truth” and “Stargate: Continuum” and won several awards for his performance as Dr. Daniel Jackson. His other TV and film credits include “The Lost Treasure of the Grand Canyon”, “Arctic Blast”, “Faces in the Crowd”, “Red Riding Hood”, “The Pastor’s Wife”, “The Twilight Zone”, “CSI: Miami”, “24”, “Stargate Atlantis”, “Burn Notice”, “Smallville”, “Supernatural”, and “Elysium”. He directed one episode of “Stargate SG-1” and wrote two others. Shanks’ more recent starring role is appearing as Dr. Charles Harris on the TV show “Saving Hope”. He has been married to his wife, Lexa Doig, since 2003, and they have three children together.
Read More

Kallam Anji Reddy’s net worth, biography, fact, career, awards and life story

K. Anji Reddy Net Worth: K. Anji Reddy was an Indian pharmacist who had a net worth of $1.5 billion. Born Kallam Anji Reddy on February 1, 1939 in Tadepalli, he made his fortune as the founder and chairman of Dr. Reddy Laboratories (DRL) Ltd., a pharmaceutical company, which listed him among world’s billionaires. A graduate of Bombay University with a B.Sc. in Pharmaceutical Science and Fine Chemicals, who had also a PhD in Chemical Engineering from National Chemical Laboratory, he formed DRL in 1984. Currently, the company is run by his son and son-in-law, and last June, it established a partnership with a division of Germany’s Merck, Merck Serone, in order to develop cancer drugs. Moreover, DRL had previously a marketing agreement with GlaxoSmithKline and a joint enterprise with Fujifilm Corp. to produce and sell generic drugs in Japan. Lately, Bristol Myers Squibb sued DRL for a supposed patent infringement of a cancer drug. Reddy served also as the chairman of Dr. Reddy’s Foundation (DRF) which he founded in 1996, as well as he was a member of the Indian Prime Minister’s Council on Trade and Industry. For his contributions to the pharmaceutical industry in India, the Government had honored him with the prestigious award Padmabhushan. K. Anji Reddy died of liver cancer on March 15, 2013.
Read More